Intravenous immunoglobulin with or without standard care vs placebo or usual care
Serious adverse events Analysis 11.2 · children with acute encephalitis
It is very uncertain whether intravenous immunoglobulin with or without standard care changes ≥ 1 serious adverse event RR (M‐H, random‐effects analysis, 95% CI) compared with standard care alone or placebo (very low certainty).
1 finding from 1 review
- Intravenous immunoglobulin for the treatment of childhood encephalitis 2017 · Cochrane Headline outcomes onlyRR 1 [0.07, 14.05]1 study · 22 participantsVery low